Institute For Neurodegenerative Disorders
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.indd.org
Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease
- First Posted Date
- 2006-04-18
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 225
- Registration Number
- NCT00315250
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
- First Posted Date
- 2006-02-06
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 38
- Registration Number
- NCT00287248
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 62
- Registration Number
- NCT00273351
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 142
- Registration Number
- NCT00134784
Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 500
- Registration Number
- NCT00132626
Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 169
- Registration Number
- NCT00129675
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 30
- Registration Number
- NCT00129181
- Locations
- 🇩🇪
Dept. of Neurology, University of Leipzig, Leipzig, Germany
🇮🇹Department of Neurological Sciences-University of Napoli, Naples, Italy
🇩🇪Dept. of Neurology Marburg, Phillips-Univ., Marburg, Germany
A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
- First Posted Date
- 2005-07-08
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 232
- Registration Number
- NCT00117819
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-07-04
- Last Posted Date
- 2012-02-09
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 620
- Registration Number
- NCT00117195
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients
Completed
- Conditions
- First Posted Date
- 2004-11-17
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 600
- Registration Number
- NCT00096876
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
© Copyright 2024. All Rights Reserved by MedPath